Healthcare provider profile · identity verified

Constance Foreman, MD

Family Practice · WILMINGTON, NC · NPI 1992199020

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	310	90
Atorvastatin Calcium	Atorvastatin Calcium	309	92
Amlodipine Besylate	Amlodipine Besylate	259	77
Losartan Potassium	Losartan Potassium	162	43
Lisinopril	Lisinopril	161	43
Omeprazole	Omeprazole	136	48
Montelukast Sodium	Montelukast Sodium	135	45
Pantoprazole Sodium	Pantoprazole Sodium	134	28
Meloxicam	Meloxicam	128	41
Gabapentin	Gabapentin	122	45
Tramadol Hcl	Tramadol Hcl	117	50
Sertraline Hcl	Sertraline Hcl	107	33
Hydrochlorothiazide	Hydrochlorothiazide	103	31
Simvastatin	Simvastatin	101	30
Tizanidine Hcl	Tizanidine Hcl	99	31
Trazodone Hcl	Trazodone Hcl	99	34
Rosuvastatin Calcium	Rosuvastatin Calcium	96	29
Metoprolol Succinate	Metoprolol Succinate	93	33
Furosemide	Furosemide	91	37
Duloxetine Hcl	Duloxetine Hcl	89	25
Albuterol Sulfate Hfa	Albuterol Sulfate	88	38
Oxycodone Hcl	Oxycodone Hcl	86	21
Alprazolam	Alprazolam	78	29
Clonazepam	Clonazepam	74	16
Bupropion Xl	Bupropion Hcl	73	16
Metformin Hcl	Metformin Hcl	72	23
Fluticasone Propionate	Fluticasone Propionate	70	32
Metoprolol Tartrate	Metoprolol Tartrate	68	19
Hydroxyzine Hcl	Hydroxyzine Hcl	65	23
Metformin Hcl Er	Metformin Hcl	65	19
Zolpidem Tartrate	Zolpidem Tartrate	57	20
Citalopram Hbr	Citalopram Hydrobromide	54	13
Alendronate Sodium	Alendronate Sodium	50	15
Chlorthalidone	Chlorthalidone	49	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	47	suppressed
Lorazepam	Lorazepam	44	15
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Potassium Chloride	Potassium Chloride	42	suppressed
Celecoxib	Celecoxib	40	19
Lovastatin	Lovastatin	38	suppressed
Prednisone	Prednisone	36	29
Allopurinol	Allopurinol	35	12
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	25
Valacyclovir	Valacyclovir Hcl	33	15
Buspirone Hcl	Buspirone Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	16
Pregabalin	Pregabalin	32	13
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Eliquis	Apixaban	30	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Estradiol	Estradiol	28	suppressed
Ezetimibe	Ezetimibe	28	11
Ozempic	Semaglutide	28	11
Carvedilol	Carvedilol	27	suppressed
Glipizide	Glipizide	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Famotidine	Famotidine	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Jardiance	Empagliflozin	21	11
Megestrol Acetate	Megestrol Acetate	21	suppressed
Valsartan	Valsartan	21	suppressed
Methocarbamol	Methocarbamol	20	12
Rybelsus	Semaglutide	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Diazepam	Diazepam	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Nystatin	Nystatin	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Fluconazole	Fluconazole	14	14
Myrbetriq	Mirabegron	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Ondansetron Odt	Ondansetron	14	suppressed
Risperidone	Risperidone	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Temazepam	Temazepam	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Carisoprodol	Carisoprodol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error